(12 March 2026, Hong Kong) — Templewater, a pan-Asian alternative asset manager, today announced the acquisition of The Women’s Clinic Group (“TWCG”), a leading Hong Kong-based provider of specialist women’s health and fertility services.
Established by pioneering medical professionals in fertility management and in vitro fertilization (“IVF”) medicine, TWCG is one of Hong Kong’s largest and most established private women’s healthcare specialist groups. Today, TWCG operates a network of six clinics, three IVF laboratories, and one blood laboratory across Hong Kong and Singapore. With a team of over 150 staff members, the group provides fertility, obstetrics and gynaecology (“O&G”), and traditional Chinese medicine consultations and care services to patients across the region.
Women’s health represents a critical and growing segment of the healthcare sector across Asia, with increasing awareness, evolving patient needs, and significant opportunities to improve access to high-quality specialist care.
Templewater will work closely with all TWCG staff members to support the group’s continued progress and long-term development.
About Templewater
Templewater is an Asia-based alternative asset manager founded in 2018. The firm provides its investors, which include global institutions, family offices and high-net worth individuals, with two core pan-Asia strategies: (a) private equity focusing on mid-market buyout, and (b) energy transition venture growth. Templewater’s mission is to provide financial and human capital, operational expertise, a corporate governance framework, and integrity to build leading businesses.
To learn more about Templewater, please visit www.templewater.com and follow Templewater on LinkedIn at www.linkedin.com/company/templewater.
About The Women’s Clinic Group Limited
TWCG is one of Hong Kong’s largest and most established private women’s healthcare specialist groups. Today, the group operates a network of six clinics, three IVF laboratories, and one blood laboratory in Hong Kong and Singapore, providing fertility treatment, obstetrics and gynaecology (“O&G”), traditional Chinese medicine, and related healthcare services to patients across the region.
To learn more about The Women’s Clinic Group, please visit https://twcg.com.hk/en/index
Media Contact
Templewater Investor Relations
+852 3187 5000
